Exchange: NASDAQ·Updated 04:10 PM EDT
NBTX logo

NBTX Nanobiotix - ADR

$33.80
$0.18
(0.53%)
Today
Closed $33.80
$0.00
(0.00%)
After Hours
EarningsMar 30
Mkt Cap$1.72B
Vol85,569.00

About NBTX

Nanobiotix SA is a late-stage biotechnology company, which engages in the development of therapeutic approaches to the treatment of cancer. Its technologies include NanoXray that improves the efficacy of radiation therapy against tumor cells. The company was founded by Laurent Lévy and Abdel Kader Boussaha on March 4, 2003 and is headquartered in Paris, France.
71

Bullish Sentiment

How do you feel about NBTX?

mktrdr59
$NBTX reaching the measured move price projections of two degrees at the Fib .618 retracement level
1
focafoca99
$NBTX announced Phase 1 data showing 41.7% response rate and 17.8-month median OS in anti-PD-1-resistant melanoma, with acceptable safety.
Rayvio_News_Filter
$NBTX 🏥 Nanobiotix S.A. reported final Phase 1 data for JNJ-1900 (NBTXR3) combined with immune checkpoint inhibitors in 24 heavily pretreated anti-PD-1-resistant primary cutaneous melanoma patients, showing an acceptable safety profile, 41.7% overall response rate, 4 complete responses, 75% disease control rate, and 17.8 months median overall survival. Curated for market relevance

Advertisement|Remove ads.